Monsanto Company (MON) Stock Rating Reaffirmed by BMO Capital Markets
Monsanto Company (NYSE:MON)‘s stock had its “buy” rating reiterated by equities research analysts at BMO Capital Markets in a note issued to investors on Thursday. They currently have a $128.00 target price on the basic materials company’s stock. BMO Capital Markets’ target price would indicate a potential upside of 6.91% from the company’s previous close.
MON has been the subject of a number of other reports. Zacks Investment Research upgraded Monsanto from a “hold” rating to a “buy” rating and set a $132.00 target price for the company in a report on Thursday, September 14th. BidaskClub upgraded Monsanto from a “sell” rating to a “hold” rating in a report on Thursday, June 29th. Macquarie downgraded Monsanto from an “outperform” rating to a “neutral” rating in a report on Wednesday. Vetr upgraded Monsanto from a “hold” rating to a “buy” rating and set a $122.35 target price for the company in a report on Tuesday, June 27th. Finally, Barclays PLC lifted their target price on Monsanto from $115.00 to $120.00 and gave the stock an “equal weight” rating in a report on Thursday, June 29th. Ten equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of $125.45.
Shares of Monsanto (NYSE:MON) opened at 119.73 on Thursday. The company has a market capitalization of $52.62 billion, a PE ratio of 23.53 and a beta of 1.07. The firm’s 50-day moving average price is $118.25 and its 200 day moving average price is $117.04. Monsanto has a one year low of $97.35 and a one year high of $120.50. Monsanto also saw unusually large options trading on Wednesday. Stock investors purchased 63,484 put options on the company. This represents an increase of 1,793% compared to the average daily volume of 3,354 put options.
Monsanto (NYSE:MON) last issued its quarterly earnings data on Wednesday, October 4th. The basic materials company reported $0.20 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.41) by $0.61. Monsanto had a return on equity of 42.40% and a net margin of 15.44%. The company had revenue of $2.69 billion during the quarter, compared to the consensus estimate of $2.51 billion. During the same period last year, the company earned $0.07 earnings per share. The firm’s revenue was up 4.8% compared to the same quarter last year. Analysts anticipate that Monsanto will post $5.65 earnings per share for the current year.
In other Monsanto news, VP Duraiswami Narain sold 2,860 shares of the firm’s stock in a transaction that occurred on Monday, September 25th. The stock was sold at an average price of $120.00, for a total value of $343,200.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Brett D. Begemann sold 22,640 shares of the firm’s stock in a transaction that occurred on Monday, September 25th. The shares were sold at an average price of $120.03, for a total value of $2,717,479.20. Following the completion of the sale, the chief operating officer now directly owns 85,439 shares of the company’s stock, valued at approximately $10,255,243.17. The disclosure for this sale can be found here. Insiders sold 77,910 shares of company stock valued at $9,242,439 in the last three months. Insiders own 0.79% of the company’s stock.
A number of institutional investors have recently made changes to their positions in MON. Pinnacle Financial Partners Inc. purchased a new position in shares of Monsanto during the second quarter valued at approximately $114,000. Bruderman Asset Management LLC purchased a new position in shares of Monsanto during the second quarter valued at approximately $116,000. Tower Research Capital LLC TRC boosted its position in shares of Monsanto by 230.1% during the second quarter. Tower Research Capital LLC TRC now owns 1,076 shares of the basic materials company’s stock valued at $128,000 after buying an additional 750 shares during the last quarter. JNBA Financial Advisors boosted its position in shares of Monsanto by 3.9% during the first quarter. JNBA Financial Advisors now owns 1,193 shares of the basic materials company’s stock valued at $135,000 after buying an additional 45 shares during the last quarter. Finally, Armbruster Capital Management Inc. boosted its position in shares of Monsanto by 12.2% during the second quarter. Armbruster Capital Management Inc. now owns 1,147 shares of the basic materials company’s stock valued at $136,000 after buying an additional 125 shares during the last quarter. 74.81% of the stock is owned by hedge funds and other institutional investors.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Stock Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related stocks with our FREE daily email newsletter.